Form 4 Tracker
Alkermes plc.
ALKS

60 insider filings · Latest: Oct 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 2, 2026Mar 2 10:07 PMGaffin David Joseph
Proposed Sale
2,034$29.29$59.6K—

View →

Mar 2, 2026Mar 2 9:36 PMHopkinson Craig C.
Proposed Sale
9,000$29.72$267.5K—

View →

Feb 2, 2026Feb 3 1:52 AMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Sale
9,000$33.93$305.4K57,740(D)

View →

Feb 2, 2026Feb 3 1:48 AMShane CookeDirector
Sale
61,200$34.57$2.1M103,744(D)

View →

Feb 2, 2026Feb 2 9:05 PMCooke Shane
Proposed Sale
61,200$34.57$2.1M—

View →

Feb 2, 2026Feb 2 9:02 PMHopkinson Craig C.
Proposed Sale
9,000$33.93$305.4K—

View →

Jan 8, 2026Jan 9 12:38 AMHopkinson Craig C.
Proposed Sale
5,000$30.00$150.0K—

View →

Jan 2, 2026Jan 2 9:36 PMHopkinson Craig C.
Proposed Sale
4,000$28.00$112.0K—

View →

Dec 3, 2025Dec 3 9:32 PMHopkinson Craig C.
Proposed Sale
3,748$30.00$112.4K—

View →

Dec 1, 2025Dec 1 9:45 PMHopkinson Craig C.
Proposed Sale
4,000$29.30$117.2K—

View →

Nov 3, 2025Nov 3 9:35 PMHopkinson Craig C.
Proposed Sale
9,000$30.38$273.4K—

View →

Oct 15, 2025Oct 15 8:07 PMHopkinson Craig C.
Proposed Sale
9,000$31.53$283.8K—

View →

Jun 10, 2025Jun 10 8:29 PMNichols Christian Todd
Proposed Sale
3,334$31.09$103.7K—

View →

Jun 9, 2025Jun 9 8:08 PMNichols Christian Todd
Proposed Sale
3,333$31.95$106.5K—

View →

Feb 13, 2025Feb 13 9:36 PMHopkinson Craig C.
Proposed Sale
144,419$35.53$5.1M—

View →

Feb 12, 2025Feb 12 9:19 PMHopkinson Craig C.
Proposed Sale
204,921$32.78$6.7M—

View →

Jan 30, 2025Jan 30 10:12 PMHopkinson Craig C.
Proposed Sale
100,918$32.05$3.2M—

View →

Dec 9, 2024Dec 9 10:27 PMLAURENCIN CATO T
Proposed Sale
2,691$31.85$85.7K—

View →

Dec 9, 2024Dec 9 10:24 PMHopkinson Craig C.
Proposed Sale
61,151$32.07$2.0M—

View →

Dec 5, 2024Dec 5 9:12 PMHopkinson Craig C.
Proposed Sale
9,221$31.50$290.5K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 8, 2026Oct 9 10:18 PMJoshua ReedSVP, Chief Financial Officer
Option Exercise
9,164—27,492(D)

View →

Oct 7, 2026Oct 9 10:16 PMAnne Clem WhitakerDirector
Grant/Award
25,237$41.4517,998(D)

View →

Sep 1, 2026Sep 1 11:08 PMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Option Exercise
5,000$24.5961,276(D)

View →

Aug 5, 2026Aug 8 1:17 AMBlair Curtis JacksonDirector, President & CEO, Alkermes plc
Grant/Award
217,534$49.61124,305(D)

View →

Aug 3, 2026Aug 3 11:16 PMNancy Lynn Snyderman MDDirector
Option Exercise
44,472$46.720(D)

View →

Aug 3, 2026Aug 3 11:12 PMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Option Exercise
5,000$24.5966,276(D)

View →

Jul 1, 2026Jul 1 10:29 PMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Option Exercise
5,000$19.341,356(D)

View →

Jun 1, 2026Jun 1 11:26 PMCraig C. HopkinsonEVP R&D, Chief Medical Officer
Option Exercise
5,000$19.346,356(D)

View →

May 29, 2026May 29 10:03 PMSamuel Joseph ParisiVP, Finance (Interim PAO)
Option Exercise
16,217$20.0312,826(D)

View →

May 21, 2026May 23 12:08 AMChristopher I WrightDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:08 AMChristopher I WrightDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:06 AMFrank Anders WilsonDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:06 AMFrank Anders WilsonDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:04 AMNancy Lynn Snyderman MDDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:04 AMNancy Lynn Snyderman MDDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:03 AMBrian P MckeonDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:03 AMBrian P MckeonDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:01 AMNancy LurkerDirector
Option Exercise
6,142—0(D)

View →

May 20, 2026May 23 12:01 AMNancy LurkerDirector
Grant/Award
16,947$36.985,409(D)

View →

May 21, 2026May 23 12:00 AMCato T LaurencinDirector
Option Exercise
6,142—0(D)

View →

Page 1 of 3

Next →